Affera combines mapping technology with a catheter capable of performing radiofrequency and pulsed field ablation.

Hurt by a slowdown in procedures for its heart valve replacement devices, Edwards said it is working with hospitals to manage ...

Teri Lawver is leaving the diabetes tech company during a challenging time, with sales slowing after a salesforce ...

Parliament asked the European Commission to publish acts that address the “most pressing challenges and bottlenecks” of the ...

Gynesonics’ transcervical system uses ultrasound guidance and radiofrequency energy to ablate fibroids without the need for ...

At Advamed’s The Medtech Conference last week, the new director of the Food and Drug Administration’s device center, Michelle ...

The second wave of the medtech industry’s latest earnings season arrives this week, with Boston Scientific, Edwards ...

Demand for the pulsed field ablation device drove the company’s electrophysiology sales up 177% in the third quarter compared ...

The AI Innovation Lab is designed to accelerate early concept artificial intelligence projects including tools to predict the ...

The company committed to closing the facility, which makes breast health products, in late 2021 and gave most employees the ...

Laboratories face a series of upcoming deadlines to comply with stricter FDA oversight of in-house tests. Here are five ...

Robert Ford’s comments come as new CGMs and insulin pumps continue to roll out in the diabetes tech space, including over-the ...